FDA approves drug to treat smallpox

Created: 2021-11-17T23:42:43-06:00

Return to the Index

This card pertains to a resource available on the internet.

FDA, 6/4/2021.

> The U.S. Food and Drug Administration today approved Tembexa (brincidofovir) to treat smallpox.

> Authorization granted without human testing.

> Tembexa received priority review, fast track and orphan drug designations.

> Tembexa was developed in conjunction with the U.S. Department of Health and Human Services’ Biomedical Advanced Research and Development Authority (BARDA). FDA granted approval of Tembexa to Chimerix Inc.